The developer of a clinical waste disposal system based on pyrolysis has received £165,000 in funding from the UK’s innovation agency, the Technology Strategy Board (TSB).
Hampshire-based PyroPure will use the grant to develop its technology, which allows the on-site disposal of hypodermic syringes and other medical sharps. It can also handle organic based waste including incontinence pad and nappy.
In May, the company announced that it was ready to come to market with a commercial-scale plant and appointed Peter Selkirk as chief executive.
Selkirk said: “The TSB backing provides us with the assurance and official recognition that PyroPure has the potential to completely reshape the current model for waste collection within hazardous environments, where waste is expensive to dispose of and where its collection bears a degree of risk.
“While pyrolysis is not new, the ability to harness its power within one small machine is, and we are confident that PyroPure is on the cusp of launching something that will irrevocably change the waste industry.”
Pyrolysis is a thermochemical decomposition process that uses high temperatures and an absence of oxygen to destroy waste.
PyroPure said its small pyrolysis plants, to be installed in hospitals and clinics, will remove the need for clinical waste to be stored, collected and then transported. They will also allow the recovery of metals and energy from hazardous materials.